ARCHIVES

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

President Signs Supplemental Funding For NIH And FDA.

July 11, 2008

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004

Final Issue of the Year

December 13, 1985

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

In brief: NCA Centers Subcommittee to Hammer Out New Proposals For Comprehensible Characteristics

September 28, 1979